TAE226 (NVP-TAE226) 化学構造
分子量: 468.94



Quality Control & MSDS


  • Compare FAK Inhibitors
  • 研究分野



情報 TAE226 (NVP-TAE226)、強力な二重FAK/IGF-IR、 FAK とIGF-IRを妨げて、IC50 がそれぞれ 5.5 nM と 0.14 μMです。
目標 FAK IGF-1R Pyk2
IC50 5.5 nM 0.14 μM 3.5 nM [1]
In vitro試験 NVP-TAE226 (< 1 μM) inhibits extracellular matrix-induced autophosphorylation of FAK (Tyr397) in serum-starved U87 cells. NVP-TAE226 (< 1 μM) also inhibits IGF-I-induced phosphorylation of IGF-1R and activity of its downstream target genes such as MAPK and Akt in both U87 and U251 cells. NVP-TAE226 (<10 μM) retards tumor cell growth and attenuats G(2)-M cell cycle progression associated with a decrease in cyclin B1 and phosphorylated cdc2 (Tyr15) protein expression in both U87 and U251 cells. NVP-TAE226 (1 μM) inhibits tumor cell invasion by at least 50% compared with the control in an in vitro Matrigel invasion assay in glioma cell lines. NVP-TAE226 (1 μM) treatment of glioma cell lines containing wild-type p53 mainly exhibits G(2)-M arrest, whereas glioma cell lines bearing mutant p53 undergoes apoptosis, as evidence by detection of caspase-3/7 activation and poly(ADP-ribose) polymerase cleavage and by an Annexin V apoptosis assay. [1] NVP-TAE226 (5 μM) inhibits phosphorylation of FAK in the human neuroblastoma cell line SK-N-AS. NVP-TAE226 (<10 μM) treatment of the human neuroblastoma cell line SK-N-AS leads to decrease in cellular viability, cell cycle arrest, and an increase in apoptosis. [2] NVP-TAE226 (0.1 μM-10 μM) inhibits tube formation of HMEC1 cells. [3]
In vivo試験 NVP-TAE226 (75 mg/kg) significantly increases the survival rate of mice bearing intracranial glioma xenografts. [1] NVP-TAE226 (100 mg/kg, oral) exerts significant decrease in microvessel density in a human colon cancer model in SCID mice. [3] NVP-TAE226 (100 mg/kg, oral) efficiently inhibits MIA PaCa-2 human pancreatic tumor growth without body weight loss in vivo model. [4] NVP-TAE226 inhibits 4T1 murine breast tumor growth and metastasis to the lung in a dose-dependent manner in vivo model, associated with inhibition of FAK autophosphorylation at Y397 and Akt phosphorylation at Serine473. [5]

推薦された実験操作 (公開の文献だけ)

細胞アッセイ: [1]

細胞系 U87 and U251 cell lines
濃度 10 μM
処理時間 5 days
方法 Cell cultures are harvested with 0.05% trypsin and seeded in triplicate at 2 × 104 in 24-well culture plates for 24 h before drug treatment. Culture medium is used for mock treatment. Cells are harvested at the indicated day after treatment, and viable cells are counted using the Vi-cell viability analyze

動物実験: [1]

動物モデル Male nude mice bearing intracranial glioma xenografts
製剤 0.5% methylcellulose
投薬量 75 mg/kg
管理 Administered via oral gavage
Solubility 0.5% methylcellulose 30 mg/mL
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesBaboonDogMonkeyRabbitGuinea pigRatHamsterMouse
Weight (kg)121031.
Body Surface Area (m2)
Km factor202012128653
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download TAE226 (NVP-TAE226) SDF
分子量 468.94


CAS No. 761437-28-9
保管 2年-20℃
6月-80℃in DMSO
溶解度 (25°C) * In vitro DMSO 94 mg/mL (200 mM)
<1 mg/mL (<1 mM)
エタノール <1 mg/mL (<1 mM)
In vivo 0.5% methylcellulose 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 Benzamide, 2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methyl-


カスタマーレビュー (1)

Click to enlarge
Source Cell Death Dis, 2014, 20, 5:e1134. TAE226 (NVP-TAE226) purchased from Selleck
Method Hemocytometer
Cell Lines Red blood cells
Concentrations 0.5 uM
Incubation Time 72 h
Results TAE226, GSK1120212 and BKM120 were able to induce synergistic cell death in combination with LBH589 validating that resistance to HDACi can be overcome by targeting actin cytoskeleton related signaling cascades. In all assays, the proportion of death induced in non-MM compartment was also assessed and ranged between 4 and 25% confirming the existence of a potential therapeutic window for the combinations evaluated.

製品表彰状 (1)



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related FAK 阻害剤


Tags: TAE226 (NVP-TAE226)を買う | TAE226 (NVP-TAE226)供給者 | TAE226 (NVP-TAE226)を購入する | TAE226 (NVP-TAE226)費用 | TAE226 (NVP-TAE226)生産者 | オーダーTAE226 (NVP-TAE226) | TAE226 (NVP-TAE226)代理店